GALECTO

Welcome to the Brand page for “GALECTO”, which is offered here for Pharmaceutical, medical and veterinary medicinal products for treatment of cancer, fibrotic diseases, autoimmune disease, neurodegenerative diseases, viral infections, acute inflammatory conditions, transplant rejection;providing medical research information, biological, chemical, pharmaceutical and clinical data in the field of diagnostic, prophylactic and therapeutic properties of pharmaceuticals for treatment of cancer, fibrotic diseases, autoimmune diseases, neurodegenerative diseases, viral infections, acute inflammatory conditions, transplant rejection, and indications hereof;.

Its status is currently believed to be active. Its class is unavailable. “GALECTO” is believed to be currently owned by “Galecto Biotech AB”.